The new calcium antagonist lercanidipine and its enantiomers affect major processes of atherogenesis in vitro: Is calcium entry involved?

Blood Pressure

Volumn 7, Issue SUPPL. 2, 1998, Pages 18-22

  Corsini, A ^a   Accomazzo, M R ^a   Canavesi, M ^a   Sartani, A ^b   Testa, R ^b   Catapano, A L ^a   Fumagalli, R ^a   Paoletti, R ^a   Bernini, F ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b Recordati SpA   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

atherosclerosis; calcium antagonists; cytosolic calcium; Fluo 3; L type channels; lercanidipine; smooth muscle cells

Indexed keywords

CALCIUM; CALCIUM ANTAGONIST; CALCIUM CHANNEL; DILTIAZEM; FIBRINOGEN; ISRADIPINE; LACIDIPINE; LERCANIDIPINE; NIFEDIPINE; VERAPAMIL; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; NITRENDIPINE;

ANIMAL CELL; AORTA; ATHEROGENESIS; CALCIUM TRANSPORT; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; ENANTIOMER; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; STEREOCHEMISTRY; ANIMAL; ARTERIOSCLEROSIS; ARTICLE; BRAIN; CELL DIVISION; CHEMISTRY; DRUG EFFECT; MEMBRANE; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; STEREOISOMERISM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; BRAIN; CALCIUM CHANNEL BLOCKERS; CELL DIVISION; DIHYDROPYRIDINES; MALE; MEMBRANES; MUSCLE, SMOOTH, VASCULAR; NITRENDIPINE; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM;

EID: 0031739126     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/080370598438500     Document Type: Article

References (25)

1. Schmitz G, Hankovitz J, Kovacs EM. Cellular processes in atherogenesis: potential targets of calcium channel blockers. Atherosclerosis 1991; 88: 109-32.
2. Nakao J, Ito H, Ooyama T, Chang W-C, Murota S. Calcium dependency of aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10,14- eicosatetraenoic acid. Effects of A23187, nicardipine and trifluoperazine. Atherosclerosis 1983; 46: 309-19.
3. Corsini A, Quarato P, Raiteri M, et al. Effect of nifedipine- atenolol association on arterial myocyte migration and proliferation. Pharmacol Res 1993; 27: 299-307.
4. Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication. Hypertension 1992; 20: 713-36.
5. Waters D, Lesperance J. Interventions that beneficially influence the evolution of coronary atherosclerosis. The case for calcium channel blockers. Circulation 1992; 86 (Suppl III): III-111-6.
6. Parmley WW. Vascular protection from atherosclerosis: potential of calcium antagonists. Am J Cardiol 1990; 66: 16-22I.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
8. Clowes AW, Clowes MM, Fingerle J. Regulation of smooth muscle cell growth injured artery. J Cardiovasc Pharmacol 1989; 14: S12-5.
9. Wissler RW. Update on the pathogenesis of atherosclerosis. Am J Med 1991; 91 (Suppl 1B): 1B-3S-9S.
10. Katsuda S, Boyd HC, Fligner C, Ross R, Gown AM. Human Atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol 1992; 140: 907-14.
11. Wissler RW, Vesselinovitch D, Komatsu A. The contribution of studies of atherosclerotic lesions in young people to future research. Ann NY Acad Sci 1990; 598: 418-34.
12. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res 1986; 58: 427-44.
13. Bianchi G, Leonardi A. Rec 15/2375. Drugs future 1987; 12: 1113-6.
14. Guarneri L, Angelico P, Ibba M, et al. Pharmacological in vitro studies of the new 1,4-dihydropiridine calcium antagonist lercanidipine. Arzneim Forsch/Drug Res 1996; 46: 15-24.
15. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 1971; 50: 172-86.
16. Corsini A, Mazzotti M, Raiteri M, et al. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis 1993; 101: 117-25.
17. Corsini A, Verri D, Raiteri M, Quarato P, Paoletti R, Fumagalli R. Effect of 26-aminocholesterol, 27-hydroxycholesterol and 25-hydroxycholesterol on proliferation and cholesterol homeostasis in arterial myocytes. Arterioscler Thromb Vasc Biol 1995; 15: 420-8.
18. Elmore E, Swift M. Growth of cultured cells from patients with Fanconi anemia. J Cell Physiol 1976; 87: 229-34.
19. Fisher RA, Yates F. Statistical tables for biological, agricultural and medical research, 4th edn. Edinburgh: Oliver & Boyd, 1953: 60.
20. Minta A, Kao JPY, Tsun RY. Fluorescent indicators for cytosolic calcium based on rhodamine and fluoroscein chromophores. J Biol Chem 1989; 264: 8171-8.
21. Nakao J, Ooyama T, Ito H, Chang W-C, Murota S. Comparative effect of lipoxygenase products of arachidonic acid on rat aortic smooth muscle cell migration. Atherosclerosis 1982; 44: 339-42.
22. Naito M, Hayashi T, Kuzuya M, Funaki C, Asai K, Kuzuya F. Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro. Atherosclerosis 1990; 83: 9-14.
23. Bernini F, Corsini A, Raiteri M, Soma MR, Paoletti R. Effects of lacidipine on experimental models of atherosclerosis. J Hypertens 1993; 11 (Suppl 3): S61-6.
24. Nayler WG, Britnell S. Calcium antagonists and tissue protection. J Cardiovasc Pharmacol 1991; 18: S1-5.
25. Sironi G, Rimoldi O, Greto L, Testa R. Effects of lercanidipine (L) and its enantiomers on systemic haemodynamics and on ventricular relaxation in chronically instrumented conscious dogs. J Mol Cell Cardiol 1995; 27: A386.